- Direction
- Deteriorating
- Own history
- 67th
- Peers
- 72th
- Persistence
- EMERGING
Health Care · Pharmaceutical Preparations
RESEARCH SNAPSHOTELI LILLY & Co's latest supported as-filed period reports revenue of $24.4B, 38.6% above the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
Separate current dimensions—not a universal score or investment ranking.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value 46.71% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 38.61% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 74.57% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 83.88% · CORE
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 0.82% · OPTIONAL
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 2 independently calculated changes: Cash & equivalents increased 165.1%; Operating cash flow increased 246.3%.
2 evidence-backed componentsThis cluster groups 2 independently calculated changes: Inventory increased 52.5%; Inventory / revenue moved 230 bp higher.
2 evidence-backed componentsThis cluster groups 2 independently calculated changes: Inventory increased 49.4%; Inventory / revenue moved 537 bp higher.
2 evidence-backed componentsCash & equivalents changed +165.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
LLY · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0000059478-26-000108SEC ↗8-KOct 29, 2026Period Oct 29, 20260000059478-26-000104SEC ↗4Oct 20, 2026Period Oct 19, 20260001262388-26-000020SEC ↗4Oct 20, 2026Period Oct 19, 20260000059478-26-000099SEC ↗4Oct 20, 2026Period Oct 19, 20260000059478-26-000097SEC ↗4Oct 20, 2026Period Oct 19, 20260001310215-26-000019SEC ↗4Sep 22, 2026Period Sep 21, 20260001262388-26-000018SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Oct 19, 2026Filed Oct 20, 2026 | Alvarez RalphDirector | Grant Or AwardDirect | 10.01 | $1,240 | $12,417 | Form 4 ↗ |
| Oct 19, 2026Filed Oct 20, 2026 | Sulzberger GabrielleDirector | Grant Or AwardDirect | 4 | $1,240 | $4,958 | Form 4 ↗ |
| Sep 21, 2026Filed Sep 22, 2026 | Sulzberger GabrielleDirector | Grant Or AwardDirect | 4.26 | $1,165 | $4,958 | Form 4 ↗ |
| Sep 9, 2026Filed Sep 11, 2026 | Seymour MelissaEVP, Global Quality | GiftDirect | 12 | $0 | $0 | Form 4 ↗ |
| Sep 2, 2026Filed Sep 4, 2026 |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Operating cash flow changed +246.3% from the comparable as-filed period.
Operating cash flow changed +29.0% from the comparable as-filed period.
Total assets changed +41.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Cash & equivalents changed -50.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Revenue changed +38.6% from the comparable as-filed period.
Revenue changed +47.7% from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-09-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0000059478-26-000091| Hernandez EdgardoEVP & Pres., Mfg. Operations |
| GiftDirect |
| 13 |
| $0 |
| $0 |
| Form 4 ↗ |
| Sep 2, 2026Filed Sep 4, 2026 | Dozier EricEVP, Chief People Officer | GiftDirect | 216 | $0 | $0 | Form 4 ↗ |
| Aug 17, 2026Filed Aug 18, 2026 | Sulzberger GabrielleDirector | Grant Or AwardDirect | 4.19 | $1,183 | $4,958 | Form 4 ↗ |
| Aug 17, 2026Filed Aug 18, 2026 | LUCIANO JUAN RDirector | Grant Or AwardDirect | 13.45 | $1,183 | $15,917 | Form 4 ↗ |
| Aug 17, 2026Filed Aug 18, 2026 | Fyrwald J ErikDirector | Grant Or AwardDirect | 8.38 | $1,183 | $9,917 | Form 4 ↗ |
| Aug 17, 2026Filed Aug 18, 2026 | Alvarez RalphDirector | Grant Or AwardDirect | 10.49 | $1,183 | $12,417 | Form 4 ↗ |
| Aug 17, 2026Filed Aug 18, 2026 | Jonsson PatrikEVP & President, LLY Int'l | Open Market SaleDirect | 6,500 | $1,175 | $7.6M | Form 4 ↗ |
| Aug 10, 2026Filed Aug 11, 2026 | Zakrowski Donald ASVP, Finance, & CAO | Open Market SaleDirect | 2,000 | $1,185 | $2.4M | Form 4 ↗ |
| Aug 7, 2026Filed Aug 10, 2026 | Hakim AnatEVP, GC & Secretary | Open Market SaleIndirect | 5,000 | $1,190 | $6.0M | Form 4 ↗ |
| Aug 1, 2026Filed Aug 3, 2026 | Seymour MelissaEVP, Global Quality | Tax WithholdingDirect | 438.71 | $1,149 | $504,004 | Form 4 ↗ |
| Aug 1, 2026Filed Aug 3, 2026 | Seymour MelissaEVP, Global Quality | Option ExerciseDirect | 981 | $0 | $0 | Form 4 ↗ |
| Aug 1, 2026Filed Aug 3, 2026 | Seymour MelissaEVP, Global Quality | Option ExerciseDirect | 981 | $0 | $0 | Form 4 ↗ |
| Jul 20, 2026Filed Jul 21, 2026 | LUCIANO JUAN RDirector | Grant Or AwardDirect | 13.88 | $1,147 | $15,917 | Form 4 ↗ |
| Jul 20, 2026Filed Jul 21, 2026 | Fyrwald J ErikDirector | Grant Or AwardDirect | 8.65 | $1,147 | $9,917 | Form 4 ↗ |
| Jul 20, 2026Filed Jul 21, 2026 | Alvarez RalphDirector | Grant Or AwardDirect | 10.83 | $1,147 | $12,417 | Form 4 ↗ |
| Jul 20, 2026Filed Jul 21, 2026 | Sulzberger GabrielleDirector | Grant Or AwardDirect | 4.32 | $1,147 | $4,958 | Form 4 ↗ |